143 related articles for article (PubMed ID: 38494932)
1. Withanone as an Emerging Anticancer Agent and Understanding Its Molecular Mechanisms: Experimental and Computational Evidence.
Stephen A; Tune BXJ; Wu YS; Batumalaie K; Sekar M; Sarker MMR; Subramaniyan V; Fuloria NK; Fuloria S; Gopinath SCB
Curr Cancer Drug Targets; 2024 Mar; ():. PubMed ID: 38494932
[TBL] [Abstract][Full Text] [Related]
2. Synthesis,
Gaurav I; Singh T; Thakur A; Kumar G; Rathee P; Kumari P; Sweta K
Curr Pharm Biotechnol; 2020; 21(15):1674-1687. PubMed ID: 32614743
[TBL] [Abstract][Full Text] [Related]
3. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
4. Ashwagandha derived withanone targets TPX2-Aurora A complex: computational and experimental evidence to its anticancer activity.
Grover A; Singh R; Shandilya A; Priyandoko D; Agrawal V; Bisaria VS; Wadhwa R; Kaul SC; Sundar D
PLoS One; 2012; 7(1):e30890. PubMed ID: 22303466
[TBL] [Abstract][Full Text] [Related]
5. Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives.
Rai M; Jogee PS; Agarkar G; dos Santos CA
Pharm Biol; 2016; 54(2):189-97. PubMed ID: 25845640
[TBL] [Abstract][Full Text] [Related]
6. Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences.
Vaishnavi K; Saxena N; Shah N; Singh R; Manjunath K; Uthayakumar M; Kanaujia SP; Kaul SC; Sekar K; Wadhwa R
PLoS One; 2012; 7(9):e44419. PubMed ID: 22973447
[TBL] [Abstract][Full Text] [Related]
7. Withanone binds to mortalin and abrogates mortalin-p53 complex: computational and experimental evidence.
Grover A; Priyandoko D; Gao R; Shandilya A; Widodo N; Bisaria VS; Kaul SC; Wadhwa R; Sundar D
Int J Biochem Cell Biol; 2012 Mar; 44(3):496-504. PubMed ID: 22155302
[TBL] [Abstract][Full Text] [Related]
8. Dual inhibition of COVID-19 spike glycoprotein and main protease 3CLpro by Withanone from
Patil VS; Hupparage VB; Malgi AP; Deshpande SH; Patil SA; Mallapur SP
Chin Herb Med; 2021 Jul; 13(3):359-369. PubMed ID: 34188665
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.
Hahm ER; Kim SH; Singh KB; Singh K; Singh SV
Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824
[TBL] [Abstract][Full Text] [Related]
10. DNA damage by Withanone as a potential cause of liver toxicity observed for herbal products of
Siddiqui S; Ahmed N; Goswami M; Chakrabarty A; Chowdhury G
Curr Res Toxicol; 2021; 2():72-81. PubMed ID: 34345852
[No Abstract] [Full Text] [Related]
11. Withania somnifera (L.) Dunal: Phytochemistry, structure-activity relationship, and anticancer potential.
Tewari D; Chander V; Dhyani A; Sahu S; Gupta P; Patni P; Kalick LS; Bishayee A
Phytomedicine; 2022 Apr; 98():153949. PubMed ID: 35151215
[TBL] [Abstract][Full Text] [Related]
12. Phyto-therapeutic potential of Withania somnifera: Molecular mechanism and health implications.
Yadav N; Tripathi S; Sangwan NS
Phytother Res; 2024 Mar; 38(3):1695-1714. PubMed ID: 38318763
[TBL] [Abstract][Full Text] [Related]
13. Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone.
Malik V; Radhakrishnan N; Kaul SC; Wadhwa R; Sundar D
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204712
[TBL] [Abstract][Full Text] [Related]
14. Selective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signaling.
Widodo N; Priyandoko D; Shah N; Wadhwa R; Kaul SC
PLoS One; 2010 Oct; 5(10):e13536. PubMed ID: 20975835
[TBL] [Abstract][Full Text] [Related]
15. Withanone, an Active Constituent from Withania somnifera, Affords Protection Against NMDA-Induced Excitotoxicity in Neuron-Like Cells.
Dar NJ; Bhat JA; Satti NK; Sharma PR; Hamid A; Ahmad M
Mol Neurobiol; 2017 Sep; 54(7):5061-5073. PubMed ID: 27541286
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic Study of Withanosides and Withanolides from
Modi SJ; Tiwari A; Ghule C; Pawar S; Saste G; Jagtap S; Singh R; Deshmukh A; Girme A; Hingorani L
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268576
[No Abstract] [Full Text] [Related]
17. Neurodegenerative diseases and Withania somnifera (L.): An update.
Dar NJ; MuzamilAhmad
J Ethnopharmacol; 2020 Jun; 256():112769. PubMed ID: 32240781
[TBL] [Abstract][Full Text] [Related]
18. In Silico Study on the Interactions, Molecular Docking, Dynamics and Simulation of Potential Compounds from
Deshpande SH; Muhsinah AB; Bagewadi ZK; Ankad GM; Mahnashi MH; Yaraguppi DA; Shaikh IA; Khan AA; Hegde HV; Roy S
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770785
[TBL] [Abstract][Full Text] [Related]
19. The Natural Products Withaferin A and Withanone from the Medicinal Herb
Chakraborty S; Mallick D; Goswami M; Guengerich FP; Chakrabarty A; Chowdhury G
J Nat Prod; 2022 Oct; 85(10):2340-2350. PubMed ID: 36098617
[TBL] [Abstract][Full Text] [Related]
20. Withanone as an inhibitor of survivin: a potential drug candidate for cancer therapy.
Wadegaonkar VP; Wadegaonkar PA
J Biotechnol; 2013 Oct; 168(2):229-33. PubMed ID: 23994265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
